The explosive growth in semaglutide (Ozempic and Wegovy) We use after its FDA approval for chronic weight management in 2021 was accompanied by another trend that drew researchers’ attention: a dramatic increase in calls to poison control centers…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply